Product Images Levetiracetam

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Levetiracetam NDC 51991-651 by Breckenridge Pharmaceutical, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - levetiracetam 01

Chemical Structure - levetiracetam 01

Figure 1 - levetiracetam 02

Figure 1 - levetiracetam 02

This is a graph displaying data on the percentage of patients with different values ranging from 0% to 40%. The graph compares the effectiveness of a placebo group versus groups taking 1000 mg/day or 3000 mg/day doses of Levetiracetam. The data is displayed through percentages and is not available for any additional interpretation.*

Figure 2 - levetiracetam 03

Figure 2 - levetiracetam 03

Figure 3 - levetiracetam 04

Figure 3 - levetiracetam 04

This seems to be a chart or graph that displays the percentage of patients at different dosage levels of a medication called Levetiracetam. The dosages shown in the data are 3000 mg/day for both a group of 104 patients labeled "Placeho" and a group of 180 patients. No further information is given in this text.*

Figure 4 - levetiracetam 05

Figure 4 - levetiracetam 05

This appears to be a comparison of two different treatments for a medical condition. The percentages indicate the proportion of patients who received each treatment - 44% received an unnamed treatment, while 19.6% received a treatment of placebo Levetiracetam. The sample sizes for each treatment group are also provided. There is no further information available to determine what medical condition is being treated or what the outcomes of the treatments were.*

Figure 5 - levetiracetam 06

Figure 5 - levetiracetam 06

The text shows a chart with percentages ranging from 0% to 40% and includes the names of two treatments called Placeho and Levetiracetam. The chart also shows the number of patients for each treatment group, but the context and purpose of the data are not available.*

Figure 6 - levetiracetam 07

Figure 6 - levetiracetam 07

This appears to be a chart presenting the percentage of patients with some kind of medical variable. The percentage values range from 0% to 100%. The chart includes 2 groups of patients, with one group given Levetiracetam and the other given a placebo. However the meaning of the variable being measured is not clear.*

PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label - levetiracetam 08

PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label - levetiracetam 08

Levetiracetam is an oral solution intended for prescription use only. The medication guide must be dispensed with each prescription. Each 473mL bottle contains 100mg/mL. Dosage recommendations should be followed for best results. The bottle should be stored at a temperature between 15-50°C (53-80°F) and kept tight with a child-resistant closure. Contact 1800-367-3395 to report any adverse reactions. Distributed by Breckenridge Pharmaceutical, Inc. and manufactured by Woodfield Pharmaceutical, LLC. Last revised in October 2020.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.